1. The Value of PET-CT in Ovarian Epithelial Carcinoma: A Population-Based Study in British Columbia, Canada
   Sarah Aurelia Cook et al, 2020, Journal of Medical Imaging and Radiation Sciences CrossRef
2. Isolated metastases in soft tissue of the chest wall in ovarian cancer: case report
   I. V Kolyadina et al, 2013, Russian Journal of Oncology CrossRef
3. Role of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in the detection of recurrence and peritoneal metastasis from ovarian cancer in correlation with cancer antigen-125 tumor marker levels
   Ghada Ali Elsayed et al, 2024, Egyptian Journal of Radiology and Nuclear Medicine CrossRef
4. 18F-FDG PET/MRI and 18F-FDG PET/CT for the Management of Gynecological Malignancies: A Comprehensive Review of the Literature
   Leila Allahqoli et al, 2023, Journal of Imaging CrossRef
5. Whole-body diffusion-weighted magnetic resonance imaging in the diagnosis of recurrent ovarian cancer: a clinical feasibility study
   Katrijn L M Michielsen et al, 2016, The British Journal of Radiology CrossRef
6. Prospective assessment of 18F-FDG PET/CT in detection of recurrent ovarian cancer
   Ghada K. Gouhar et al, 2013, The Egyptian Journal of Radiology and Nuclear Medicine CrossRef
7. Diagnostic performance of 18F-FDG PET/contrast-enhanced CT versus contrast-enhanced CT alone for post-treatment detection of ovarian malignancy
   Ahmed Tawakol et al, 2016, Nuclear Medicine Communications CrossRef
8. PET/MR Imaging in Gynecologic Oncology
   Michael A. Ohliger et al, 2017, Magnetic Resonance Imaging Clinics of North America CrossRef
9. N ‐acetylaspartate release by glutaminolytic ovarian cancer cells sustains protumoral macrophages
   Alessio Menga et al, 2021, EMBO reports CrossRef
10. Which imaging technique should we use in the follow up of gynaecological cancer?
    Antonia Carla Testa et al, 2014, Best Practice & Research Clinical Obstetrics & Gynaecology CrossRef
11. Diagnostic value of positron emission tomography (PET) and PET/computed tomography in recurrent/metastatic ovarian cancer: A meta‐analysis
    Bo Xu et al, 2017, Journal of Obstetrics and Gynaecology Research CrossRef
12. Nuclear Medicine for Imaging of Epithelial Ovarian Cancer
    Seyed Mohammad Abedi et al, 2016, Future Oncology CrossRef
13. Diagnostic Applications of Nuclear Medicine: Ovarian Cancer
    Neeta Pandit-Taskar et al, 2016, Nuclear Oncology CrossRef
14. Methylation-mediated repression of MiR-424/503 cluster promotes proliferation and migration of ovarian cancer cells through targeting the hub gene KIF23
    Tong Li et al, 2019, Cell Cycle CrossRef
15. Diagnostic Applications of Nuclear Medicine: Ovarian Cancer
    Neeta Pandit-Taskar et al, 2022, Nuclear Oncology CrossRef
16. An update on post-treatment surveillance and diagnosis of recurrence in women with gynecologic malignancies: Society of Gynecologic Oncology (SGO) recommendations
    Ritu Salani et al, 2017, Gynecologic Oncology CrossRef
17. Detecting recurrent ovarian cancer: revisit the values of whole-body CT and serum CA 125 levels
    Pieh-Hsu Wang et al, 2019, Acta Radiologica CrossRef
18. Diagnostic Applications of Nuclear Medicine: Ovarian Cancer
    Neeta Pandit-Taskar et al, 2022, Nuclear Oncology CrossRef
19. The role of CT, PET-CT, and MRI in ovarian cancer
    Maurits Peter Engbersen et al, 2021, The British Journal of Radiology CrossRef
20. Role of 18F FDG PET/CT in evaluation of post-operative ovarian carcinoma
    Marwa Ibrahim El-Sayed Amer et al, 2022, Egyptian Journal of Radiology and Nuclear Medicine CrossRef
21. Diagnostic Applications of Nuclear Medicine: Ovarian Cancer
    Neeta Pandit-Taskar et al, 2022, Nuclear Oncology CrossRef
22. Diagnostic Applications of Nuclear Medicine: Ovarian Cancer
    Neeta Pandit-Taskar et al, 2017, Nuclear Oncology CrossRef
23. An update on the role of PET/CT and PET/MRI in ovarian cancer
    Benjapa Khiewvan et al, 2017, European Journal of Nuclear Medicine and Molecular Imaging CrossRef
24. Usefulness of PET–CT in the evaluation of suspected recurrent ovarian carcinoma
    Mona Abdel Ghaffar ElHariri et al, 2019, Egyptian Journal of Radiology and Nuclear Medicine CrossRef
25. Metabolic shifts toward glutamine regulate tumor growth, invasion and bioenergetics in ovarian cancer
    Lifeng Yang et al, 2014, Molecular Systems Biology CrossRef
26. Clinical and Survival Impact of FDG PET in Patients with Suspicion of Recurrent Ovarian Cancer: A 6-Year Follow-Up
    Daniela Rusu et al, 2015, Frontiers in Medicine CrossRef
27. Sarcoidosis manifesting as hepatic and splenic nodules mimicking ovarian cancer metastases: A case report
    YOSHIKUNI YONENAGA et al, 2015, Oncology Letters CrossRef